134 related articles for article (PubMed ID: 36115511)
1. Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic Tumors.
Geiersbach KB; Gliem TJ; Jenkins SM; Gaitatzes AG; Brodersen PR; Negro ME; Clees MJ; Swanson KE; Boeckman RM; Natrop TJ; Sukov WR; Shah KK; Greipp PT; Rowsey RA; Flotte TJ; Erickson LA; Guo R
J Mol Diagn; 2022 Nov; 24(11):1160-1170. PubMed ID: 36115511
[TBL] [Abstract][Full Text] [Related]
2. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
[TBL] [Abstract][Full Text] [Related]
3. Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray.
Hedayat AA; Linos K; Jung HS; Tafe LJ; Yan S; LeBlanc RE; Lefferts JA
Exp Mol Pathol; 2017 Dec; 103(3):279-287. PubMed ID: 29169801
[TBL] [Abstract][Full Text] [Related]
4. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
5. Atypical Spitz Tumors: A Diagnostic Challenge.
Harms KL; Lowe L; Fullen DR; Harms PW
Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
[TBL] [Abstract][Full Text] [Related]
6. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
Urso C
Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323
[TBL] [Abstract][Full Text] [Related]
7. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
Gammon B; Gerami P
Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
[TBL] [Abstract][Full Text] [Related]
10. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
11. DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approach.
Alomari AK; Miedema JR; Carter MD; Harms PW; Lowe L; Durham AB; Fullen DR; Patel RM; Hristov AC; Chan MP; Wang M; Andea AA
Mod Pathol; 2020 Jul; 33(7):1307-1317. PubMed ID: 32066860
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
13. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
14. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
15. [Morphological and genetic aspects of Spitz tumors].
Wiesner T; Kutzner H
Pathologe; 2015 Feb; 36(1):37-43, 45. PubMed ID: 25613920
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
17. BAP1-deficient tumor/nevus with germline aberration: A potential pitfall in assessing melanocytic neoplasms with single nucleotide polymorphism array.
Hedayat AA; Lefferts JA; Atkinson AE; Busam KJ; Linos K
J Cutan Pathol; 2019 Sep; 46(9):672-677. PubMed ID: 31058349
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
[TBL] [Abstract][Full Text] [Related]
19. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
20. Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms.
Reimann JDR; Salim S; Velazquez EF; Wang L; Williams KM; Flejter WL; Brooke L; Sunder S; Busam KJ
Mod Pathol; 2018 Nov; 31(11):1733-1743. PubMed ID: 29955141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
